Miromatrix Medical Inc.
MIRO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 31.2% | 6.7% | -99.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -1,018.5% | -1,367.7% | -1,466.2% | 86.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -55,031.4% | -73,180.8% | -85,713.4% | -745.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -57,746% | -76,675.1% | -90,091.8% | -746.6% |
| EPS Diluted | -0.24 | -0.24 | -0.32 | -0.33 |
| % Growth | 0% | 25% | 3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |